Health Trials

Moderate to Severe Refractory Autoimmune Disease

1

Review clinical trials related to Moderate to Severe Refractory Autoimmune Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases

This is a single-arm, open-label, dose-escalation and dose-expansion clinical trial designed to evaluate the safety, efficacy, and cellular metabolism kinetics of GT801 in the treatment of moderate-to-severe refractory autoimmune diseases. Interim analysis will be conducted when 5 patients complete primary endpoint measurement.

Participants needed: 22
Trial details
Phase: Early Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Grit BiotechnologyUpdated: May 27, 2026Locations: 1
Eligibility criteria

1. The participant or their legal representative voluntarily signs a written inf... [+34]

1. Participants with SLE [+51]

Read more